Last edition
News about Industrial talks
ACG appoints V Ashok as Group Chief Financial Officer
ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, is pleased to announce the appointment of V. Ashok as the Group CFO. In his new role he will drive global growth, strengthen corporate governance, and build a future ready organization
Industrial talks | 06/07/2021 | By Darshana | 600
Molbio Diagnostics, one of India's leading healthcare companies in the in-vitro diagnostics segment, launched a new manufacturing unit for its innovative molecular diagnostic platform - Truenat Real-Time PCR, spread across 1,35,000 Sq.ft, in Verna, Goa.
Industrial talks | 01/07/2021 | By Darshana | 612
Management of patient's recovery from effects of COVID 19 is the key focus point to going back to normalcy. To help the patient recover faster, Mumbai based Pharma, Healthcare & Nutraceutical supplement maker Adroit Biomed Limited today launched its immunity enhancing tablets Glutone MD
Industrial talks | 30/06/2021 | By Darshana | 647
Rockwell Industries, a commercial cold chain appliance manufacturer, has entered into a strategic partnership with Dr Reddy's Laboratories (DRL), to provide its WHO PQS (World Health Organisation - Performance, Quality and Safety) certified Covid-19 vaccine freezers to enable storage of Sputnik V vaccine across India
Industrial talks | 09/06/2021 | By Darshana | 296
Trivitron Healthcare launches advanced diagnostic solutions for HbA1c based on HPLC technology
Trivitron Healthcare has launched two new products "NANO H5 and NANO H110" for HbA1c- and Hb- variant detection. These products are High Performace Liquid Chromatography (HPLC) analysers for HbA1c detection in less than three minutes. These will be used for monitoring diabetes, thalassemia and haemoglobin variants, a company statement said
Industrial talks | 02/06/2021 | By Darshana | 428
Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca
Sun Pharmaceutical Industries Ltd has acquired the rights to trademarks of diabetes drug dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, the parent company of AstraZeneca Pharma India
Industrial talks | 30/05/2021 | By Darshana | 632
PharmEasy completes acquisition of Medlife
The acquisition which took place in January 2021, was aimed at creating a strong unified platform to accelerate the mission of providing quality healthcare to a larger population
Industrial talks | 26/05/2021 | By Darshana | 411
Bharat Biotech expects WHO emergency listing for Covaxin by July-September 2021
Bharat Biotech stated that it has submitted application for WHO Emergency Use Listing (EUL) for Covaxin, and regulatory approvals are expected in July-September, 2021
Industrial talks | 26/05/2021 | By Darshana | 207
Moderna, Aldevron extends partnership for mRNA vaccine and therapeutic pipeline
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna
Industrial talks | 25/05/2021 | By Darshana | 288
RDIF in discussions on production of Sputnik V for other countries, Dr Reddy's
Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of COVID-19 vaccine Sputnik V in India, is holding parleys with RDIF for acquiring rights for more countries, a senior official of the Indian company said. Dr Reddy's, which had received over two lakh vaccines from RDIF
Industrial talks | 20/05/2021 | By Darshana | 234
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy